Joyzyme Group Limited (HKG:8622)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.350
+0.005 (1.45%)
At close: Mar 10, 2026
9.38%
Market Cap 180.42M
Revenue (ttm) 28.24M
Net Income (ttm) -5.20M
Shares Out 515.47M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 872,000
Average Volume 306,000
Open 0.335
Previous Close 0.345
Day's Range 0.335 - 0.360
52-Week Range 0.275 - 0.750
Beta 0.64
RSI 42.66
Earnings Date Mar 25, 2026

About Joyzyme Group

Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. The company was formerly known as ... [Read more]

Sector Healthcare
Founded 1992
Employees 98
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8622
Full Company Profile

Financial Performance

In 2024, Joyzyme Group's revenue was 25.36 million, an increase of 2.96% compared to the previous year's 24.63 million. Losses were -4.16 million, -28.09% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.